Author: "Hussar, Daniel A." - Searchworks@Jio Institute Digital Library Search Results

Author: Hussar, Daniel A.
Subjects: Drugs -- Dosage and administration, Drugs -- Product information, Health
Abstract: Fourteen new drugs that include ustekimumab, dronedarone HCl, prasugrel HCl, and abobotulinumtoxinA are discussed. The precautions, adverse reactions, dosage, and nursing considerations for these drugs are discussed.
Published: 2010

Author: Hussar, Daniel A.
Subjects: Drugs, Health
Abstract: An overview of 16 new drugs that include the analgesic Tapendtadol HCI, Fibromyalgia drug Milnacipran HCI, and Fesoterodine fumarate for overactive bladders. Silodosin, Goliumamab, Lacosamide, and Rufinamide are also described.
Published: 2010

Author: Hussar, Daniel A.
Subjects: Drugs -- Product information, Drugs -- Dosage and administration, Drug approval, Health
Abstract: Information about six new drugs is presented. These include clevidipine butyrate, romiplostim and eltrombopag olamine, C1 inhibitor, difluprednate, and tetrabenazine. Other information such as precautions, adverse reactions, dosage, and nursing considerations, is also provided.
Published: 2009

Author: Hussar, Daniel A.
Subjects: Drugs -- Product information, Drug interactions, Health
Abstract: Information about 10 new drugs, which include nebivolol HCl, methylnaltrexone bromide, and alvimopan, is presented. The information provided applies to adults, unless otherwise specified. The need to consult pharmacists or a comprehensive drug reference for more details on drug interactions and precautions is also discussed.
Published: 2009

Author: Hussar, Daniel A.
Subjects: Doripenem -- Complications and side effects, Doripenem -- Dosage and administration, Maraviroc -- Complications and side effects, Maraviroc -- Dosage and administration, Ixabepilone -- Complications and side effects, Ixabepilone -- Dosage and administration, Nursing care -- Methods, Health
Abstract: The article presents details of new drugs introduced on the market for treatment of different ailments. The dosage, adverse reactions, methods of administration and precautions that nurse should observe are highlighted.
Published: 2008

Author: Hussar, Daniel A.
Subjects: Hypoglycemic agents, Antiviral agents, Antifungal agents, Antiparkinsonian agents, Photosensitizing compounds, Antimitotic agents, Antineoplastic agents, Smoking cessation products, Health
Published: 2007

Author: Hussar, Daniel A.
Subjects: Nursing -- Practice, Health care industry -- Research, Drugs -- Dosage and administration, Bacterial infections -- Drug therapy, Heart failure -- Drug therapy, HIV infection -- Drug therapy, Health
Abstract: This article describes 10 new drugs marketed in the second half of 2001. Among the most significant are drotrecogin alfa, for severe sepsis in adults, nesiritide, for acute heart failure, and tenofovir disoproxil fumarate, approved to treat HIV infection.
Published: 2002

Author: Hussar, Daniel A.
Subjects: Pharmaceutical industry -- Product introduction, Drugs -- Dosage and administration, Asthma -- Drug therapy, Formoterol -- Dosage and administration, Angioplasty -- Drug therapy, Anticoagulants (Medicine) -- Innovations, Hepatitis C -- Drug therapy, Interferon alpha -- Dosage and administration, Antifungal agents -- Innovations, Skin -- Wrinkles, Botulinum toxin -- Health aspects, Lymphocytic leukemia -- Drug therapy, Monoclonal antibodies -- Health aspects, Chronic myeloid leukemia -- Drug therapy, Contraceptives -- Innovations, Health
Abstract: Eight new drugs introduced in 2002 are described. They include the new contraceptive drospirenone-ethinyl estradiol, the new antifungal drug caspofungin acetate, the new anticoagulant bivalirudin, which is used for patients undergoing percutaneous transluminal coronary angioplasty and two new leukemia drugs, alemtuzumad and imatinib mesylate.
Published: 2002